MedPath

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Active, not recruiting
Conditions
Age-Related Macular Degeneration
Interventions
Other: No intervention
Registration Number
NCT05300724
Lead Sponsor
Genentech, Inc.
Brief Summary

This is a multicenter prospective study in participants with intermediate age-related macular degeneration (iAMD). One primary objective of this study is to assess iAMD disease progression, by the timeline and rates of conversion for high-risk iAMD at baseline to more advanced atrophic AMD stages. The other primary objective of this observational study is to assess the feasibility of measuring the rate of photoreceptor loss as a potential clinical endpoint. The study will consist of an observation period of approximately 3 years (\~144 weeks) for participants.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • For women of childbearing potential, agreement to remain abstinent (refrain from heterosexual intercourse) or use contraception, during the study for at least 28 days after the last fluorescein injection for the fluorescein angiography (FA) administration
  • Study eye: High-risk intermediate AMD
Exclusion Criteria
  • Macular disease in either eye with subretinal deposits not typical of AMD
  • Pigmentary abnormalities of the retina in either eye not typical of AMD
  • Atrophy in either eye due to causes other than AMD
  • Study eye: Any concurrent or history of ocular or intraocular condition
  • Study eye: Intraocular surgery, including cataract surgery, within 3 months prior to Day 1
  • Study eye: Retinal tears or peripheral retinal breaks within 3 months prior to Day 1
  • Study eye: Concurrent or history of retinal laser photocoagulation or anti-vascular endothelial growth factor (anti-VEGF) treatment for exudative MNV, diabetic macular edema, retinal vein occlusion, or proliferative diabetic retinopathy
  • Study eye: Presence of choroidal nevus with overlying drusen in the circle with a radius 3600 micrometer centered on the fovea
  • Study eye: Previous participation in interventional clinical trials for GA or early stages of AMD, except for vitamins and minerals, regardless of the route of administration within the last 6 months, except for sham-arm participants
  • Study eye: History of glaucoma surgery, corneal transplant, retinal pigment epithelium tear, retinal tear that involves the macula, retinal detachment
  • Either eye: Uncontrolled progressive glaucoma
  • Either eye: Moderate or severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy
  • Either eye: History of recurrent infectious or inflammatory ocular disease
  • Any concurrent or history of taking medications that can induce retinal toxicity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Intermediate AMDNo interventionParticipants with iAMD will be evaluated for the progression of iAMD to more advanced atrophic AMD stages, such as nascent geographic atrophy (nGA) or incomplete retinal pigment epithelium and outer retinal atrophy (iRORA), and subsequently from nGA or iRORA to complete retinal pigment epithelium (cRORA) and outer retinal atrophy or geographic atrophy (GA), on Day 1 and thereafter every 12 weeks up to the end of the Observation Period, approximately 3 years.
Primary Outcome Measures
NameTimeMethod
Rate of Conversion from iAMD to nGA /iRORABaseline up to 3 years
Rate of Conversion from nGA/iRORA to cRORA/GABaseline up to 3 years
Rate of Photoreceptor Loss as Assessed by Spectral Domain Optical Coherence Tomography (SD-OCT)Baseline up to 3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (75)

Cleveland Clinic Cole Eye Institute

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland, Ohio, United States

Universitรคtsklinikum Bonn

๐Ÿ‡ฉ๐Ÿ‡ช

Bonn, Germany

Rabin Medical Center

๐Ÿ‡ฎ๐Ÿ‡ฑ

Petach Tikva, Israel

Azienda Sanitaria Universitaria Friuli Centrale ? PO Universitario Santa Maria della Misericordia

๐Ÿ‡ฎ๐Ÿ‡น

Udine, Friuli-Venezia Giulia, Italy

Retina Partners of Northwest Arkansas, PLLC

๐Ÿ‡บ๐Ÿ‡ธ

Springdale, Arkansas, United States

The Retina Partners

๐Ÿ‡บ๐Ÿ‡ธ

Encino, California, United States

Retina Consultants of Orange County

๐Ÿ‡บ๐Ÿ‡ธ

Fullerton, California, United States

Northern California Retina Vitreous Associates

๐Ÿ‡บ๐Ÿ‡ธ

Mountain View, California, United States

Retina Consultants, San Diego

๐Ÿ‡บ๐Ÿ‡ธ

Poway, California, United States

UC Davis Eye Center

๐Ÿ‡บ๐Ÿ‡ธ

Sacramento, California, United States

Retinal Consultants Medical Group

๐Ÿ‡บ๐Ÿ‡ธ

Sacramento, California, United States

Bay Area Retina Associates

๐Ÿ‡บ๐Ÿ‡ธ

Walnut Creek, California, United States

Southwest Retina Consultants

๐Ÿ‡บ๐Ÿ‡ธ

Durango, Colorado, United States

Eye Care Center of Northern Colorado PC

๐Ÿ‡บ๐Ÿ‡ธ

Longmont, Colorado, United States

Advanced Research

๐Ÿ‡บ๐Ÿ‡ธ

Coral Springs, Florida, United States

Rand Eye Institute

๐Ÿ‡บ๐Ÿ‡ธ

Deerfield Beach, Florida, United States

National Ophthalmic Research Institute

๐Ÿ‡บ๐Ÿ‡ธ

Fort Myers, Florida, United States

Florida Eye Associates

๐Ÿ‡บ๐Ÿ‡ธ

Melbourne, Florida, United States

Southeast Retina Center

๐Ÿ‡บ๐Ÿ‡ธ

Augusta, Georgia, United States

University Retina and Macula Associates, PC

๐Ÿ‡บ๐Ÿ‡ธ

Oak Forest, Illinois, United States

Raj K. Maturi, MD PC

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Wolfe Eye Clinic

๐Ÿ‡บ๐Ÿ‡ธ

West Des Moines, Iowa, United States

Cumberland Valley Retina Consultants PC

๐Ÿ‡บ๐Ÿ‡ธ

Hagerstown, Maryland, United States

New England Retina Consultants

๐Ÿ‡บ๐Ÿ‡ธ

Springfield, Massachusetts, United States

Foundation for Vision Research

๐Ÿ‡บ๐Ÿ‡ธ

Grand Rapids, Michigan, United States

Deep Blue Retina Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Southaven, Mississippi, United States

Sierra Eye Associates

๐Ÿ‡บ๐Ÿ‡ธ

Reno, Nevada, United States

Eye Associates of New Mexico

๐Ÿ‡บ๐Ÿ‡ธ

Albuquerque, New Mexico, United States

Vitreous Retina Macula Consultants of New York

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Ophthalmic Consultants of Long Island

๐Ÿ‡บ๐Ÿ‡ธ

Rockville Centre, New York, United States

Duke Eye Center

๐Ÿ‡บ๐Ÿ‡ธ

Durham, North Carolina, United States

Retina Vitreous Center

๐Ÿ‡บ๐Ÿ‡ธ

Edmond, Oklahoma, United States

EyeHealth Northwest

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Casey Eye Institute - OHSU

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Erie Retinal Surgery

๐Ÿ‡บ๐Ÿ‡ธ

Erie, Pennsylvania, United States

Scheie Eye Institute

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

Palmetto Retina Center, LLC

๐Ÿ‡บ๐Ÿ‡ธ

West Columbia, South Carolina, United States

Tennessee Retina PC

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

W Texas Retina Consultants PA

๐Ÿ‡บ๐Ÿ‡ธ

Abilene, Texas, United States

Austin Retina Associates

๐Ÿ‡บ๐Ÿ‡ธ

Austin, Texas, United States

Austin Clinical Research LLC

๐Ÿ‡บ๐Ÿ‡ธ

Austin, Texas, United States

Retina Consultants of Texas

๐Ÿ‡บ๐Ÿ‡ธ

Bellaire, Texas, United States

Retina Foundation of the Southwest

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

Retina Specialists

๐Ÿ‡บ๐Ÿ‡ธ

DeSoto, Texas, United States

San Antonio Eye Center

๐Ÿ‡บ๐Ÿ‡ธ

San Antonio, Texas, United States

Rocky Mountain Retina

๐Ÿ‡บ๐Ÿ‡ธ

Salt Lake City, Utah, United States

Wagner Kapoor Institute

๐Ÿ‡บ๐Ÿ‡ธ

Norfolk, Virginia, United States

Spokane Eye Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Spokane, Washington, United States

West Virginia University Eye Institute

๐Ÿ‡บ๐Ÿ‡ธ

Morgantown, West Virginia, United States

University of Wisconsin Hospital and Clinics

๐Ÿ‡บ๐Ÿ‡ธ

Madison, Wisconsin, United States

Marsden Eye Specialists

๐Ÿ‡ฆ๐Ÿ‡บ

Parramatta, New South Wales, Australia

Sydney Retina Clinic and Day Surgery

๐Ÿ‡ฆ๐Ÿ‡บ

Sydney, New South Wales, Australia

Adelaide Eye and Retina Centre

๐Ÿ‡ฆ๐Ÿ‡บ

Adelaide, South Australia, Australia

Centre For Eye Research Australia

๐Ÿ‡ฆ๐Ÿ‡บ

East Melbourne, Victoria, Australia

The Lions Eye Institute

๐Ÿ‡ฆ๐Ÿ‡บ

Nedlands, Western Australia, Australia

Centre Hospitalier Intercommunal

๐Ÿ‡ซ๐Ÿ‡ท

Creteil, France

Centre Ophtalmologique Pole Vision

๐Ÿ‡ซ๐Ÿ‡ท

Ecully, France

CHU de GRENOBLE

๐Ÿ‡ซ๐Ÿ‡ท

Grenoble, France

Hรดpital de La Croix Rousse

๐Ÿ‡ซ๐Ÿ‡ท

Lyon, France

Centre Ophtalmologique Maison-Rouge

๐Ÿ‡ซ๐Ÿ‡ท

Strasbourg, France

Universitรคtsklinikum Freiburg

๐Ÿ‡ฉ๐Ÿ‡ช

Freiburg, Germany

University Medicine Gottingen Germany

๐Ÿ‡ฉ๐Ÿ‡ช

Gottingen, Germany

Medizinische Hochschule Hannover, Innere Abteilung/Pneumologie

๐Ÿ‡ฉ๐Ÿ‡ช

Hannover, Germany

Universitatsklinikum Leipzig

๐Ÿ‡ฉ๐Ÿ‡ช

Leipzig, Germany

Universitatsklinikum Munster

๐Ÿ‡ฉ๐Ÿ‡ช

Mรผnster, Germany

Augenzentrum am St Franziskus-Hospital

๐Ÿ‡ฉ๐Ÿ‡ช

Mรผnster, Germany

Universitรคtsklinikum Tรผbingen

๐Ÿ‡ฉ๐Ÿ‡ช

Tรผbingen, Germany

Rambam Medical Center - PPDS

๐Ÿ‡ฎ๐Ÿ‡ฑ

Haifa, Israel

Tel Aviv Sourasky Medical Center PPDS

๐Ÿ‡ฎ๐Ÿ‡ฑ

Jerusalem, Israel

Hadassah Medical Center

๐Ÿ‡ฎ๐Ÿ‡ฑ

Jerusalem, Israel

Fondazione G.B. Bietti Per Lo Sudio E La Ricerca In Oftalmologia-Presidio Ospedaliero Britannico

๐Ÿ‡ฎ๐Ÿ‡น

Roma, Lazio, Italy

Ospedale S. Giuseppe Multimedica

๐Ÿ‡ฎ๐Ÿ‡น

Milano, Lombardia, Italy

Ospedale San Raffaele S.r.l. - PPDS

๐Ÿ‡ฎ๐Ÿ‡น

Milano, Lombardia, Italy

ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco

๐Ÿ‡ฎ๐Ÿ‡น

Milano, Lombardia, Italy

Emanuelli Research and Development Center LLC

๐Ÿ‡ต๐Ÿ‡ท

Arecibo, Puerto Rico

ยฉ Copyright 2025. All Rights Reserved by MedPath